Introduction {#s1}
============

People living with chronic health problems can benefit from self-management education [@pone.0065316-Newman1], [@pone.0065316-Mulligan1], [@pone.0065316-Expert1], [@pone.0065316-Chronic1]. Educational programs aimed at increasing the skills and confidence for self-management can reduce pain, fatigue, disability, anxiety, and depression, and they can improve self-rated general health. Regarding health-related behaviors, the benefits include increases in aerobic exercise and in symptom management [@pone.0065316-Foster1], [@pone.0065316-Barlow1], [@pone.0065316-Tousman1], [@pone.0065316-Franks1], [@pone.0065316-Jerant1], [@pone.0065316-Gitlin1], [@pone.0065316-Siu1].

Because the health conditions that these programs address are chronic, attention must be paid to how long the programs' benefits last. It has been noted that "short-term effects are rarely maintained over long intervals" [@pone.0065316-Riemsma1] and that such programs' "effects tend not to be maintained" [@pone.0065316-Mulligan1]. This phenomenon has been given various names: attenuation [@pone.0065316-Franks1], [@pone.0065316-Lorig1], deterioration [@pone.0065316-Clark1], relapse [@pone.0065316-Caplin1], backsliding [@pone.0065316-Green1], and decay of impact (which is the name we use here) [@pone.0065316-Green1]. Decay of impact may not be universal [@pone.0065316-Barlow1], [@pone.0065316-Barlow2], but it has been noted at the whole-group level in many studies \[8, 13 14, 15, 18, 19, 20\].

For long-term benefits, the decay of impact must therefore be minimized or prevented. To that end, "booster sessions" [@pone.0065316-Newman1] have been proposed as reinforcements. In the present context, the term "reinforcement" refers to interventions that are intended to help the participants maintain the benefits of the main educational program. These interventions take place after the main program ends. In addition to group-discussion booster sessions [@pone.0065316-Riemsma2], [@pone.0065316-Lorig2], reinforcements have also been implemented as an online discussion group to provide peer support [@pone.0065316-Lorig3], an Internet-based program as a follow-up after a face-to-face intervention [@pone.0065316-Nguyen1], telephone calls from a health counselor [@pone.0065316-Glasgow1], automated telephone calls [@pone.0065316-Lorig4], and printed materials sent to people who had participated in the main program [@pone.0065316-Lorig2], [@pone.0065316-Glasgow1]. Studies of reinforcements indicate that they do not consistently provide important benefits (see the Appendix of reference [@pone.0065316-Park1]). To explain why they appear to be ineffective, it has been hypothesized that "decay of impact occurs only in a subgroup of these programs' participants, so any benefits of reinforcements in that subgroup are concealed by whole-group summary statistics." [@pone.0065316-Park1] Here we demonstrate how evidence relevant to that hypothesis can be obtained from a longitudinal cohort study. Specifically, we show how analysis of individual-level data reveals the decay of impact that analysis of whole-group data leaves hidden.

It stands to reason that reinforcements can be optimized on the basis of a clear and accurate understanding of the phenomenon that they are intended to prevent or mitigate. For example, knowledge of when the decay of impact begins could be used to decide when to begin reinforcements [@pone.0065316-Hennessy1]. Such basic characteristics of the decay of impact as its timing, prevalence, and magnitude have important practical implications, but those characteristics are unknown because the decay itself has not been an object of study. Therefore, here we also report the prevalence, timing, and magnitude of the decay of impact with regard to two well-defined clinical conditions: anxiety and depression. To the best of our knowledge, no such description of this decay of impact has previously been published.

Methods {#s2}
=======

Participants in the Self-management Program {#s2a}
-------------------------------------------

We analyzed data provided by people with various chronic medical conditions who took part in an educational program aimed at enhancing their ability and confidence to self-manage their chronic illnesses [@pone.0065316-Chronic1], [@pone.0065316-Lorig5]. They were recruited using an announcement on the Internet homepage of the Japan Chronic Disease Self-Management Association [@pone.0065316-Japan1], and by referrals from flyers left in public service centers. All of the participants were adults, both men and women participated, and they had a wide variety of chronic medical conditions. Socio-demographic information about the participants is shown in [Table 1](#pone-0065316-t001){ref-type="table"}, together with information on their chronic conditions (number of years since diagnosis, numbers of diagnoses, and numbers of participants with each of the most common conditions).

10.1371/journal.pone.0065316.t001

###### Demographic and clinical characteristics of the participants in this study (n = 369).

![](pone.0065316.t001){#pone-0065316-t001-1}

                                                                                   Number (%)
  --------------------------------------------- ----------------------------- ---------------------
  Age (years)                                         mean ± SD (range)        49.2±14.0 (19--83)
  Sex                                                       Male                   73 (19.8%)
                                                           Female                  296 (80.2%)
  Schooling                                          High school or less           187 (50.7%)
                                                       College or more             182 (49.3%)
  Civil status                                   Living together with spouse       200 (54.2%)
                                                           Others                  169 (45.8%)
  Years since diagnosis                               mean ± SD (range)        13.6±12.1 (0.5--63)
                                                      median (25%, 75%)         10.0 (4.0, 20.0)
  Number of diagnoses                                 median (25%, 75%)          1.0 (1.0, 2.0)
                                                           min-max                    1--7
                                                              1                    197 (53.4%)
                                                              2                    99 (26.8%)
                                                              3                    48 (13.0%)
                                                             ≥4                     25 (6.8%)
  Diagnoses[(a)](#nt101){ref-type="table-fn"}         Allergic disease             92 (24.9%)
                                                   Cardiovascular disease          72 (19.5%)
                                                  Connective tissue disease        67 (18.2%)
                                                          Diabetes                 65 (17.6%)
                                                    Rheumatoid arthritis           46 (12.5%)
                                                    Fibromyalgia syndrome           31 (8.4%)
                                                           Cancer                   26 (7.0%)
                                                         Depression                 22 (6.0%)
                                                           Asthma                   16 (4.3%)
                                                 Inflammatory bowel disease         14 (3.8%)
                                                     Parkinson's disease            12 (3.3%)
                                                           Others                  145 (39.3%)

Includes multiple conditions.

The Self-management Program {#s2b}
---------------------------

The program comprised group-discussion sessions with 5 to 13 participants. The discussions focused on six topics: "1) techniques to deal with problems such as frustration, fatigue, pain and isolation, 2) appropriate exercise for maintaining and improving strength, flexibility, and endurance, 3) appropriate use of medications, 4) communicating effectively with family, friends, and health professionals, 5) nutrition, and, 6) how to evaluate new treatments." [@pone.0065316-Chronic1] Those topics are introduced in a textbook [@pone.0065316-Lorig6], [@pone.0065316-Lorig7]. Through their discussions, the participants realize how others have experienced and responded to problems similar to their own, even if their diagnoses are different. They talk about how to manage those problems. They learn some self-management skills from the textbook and they also learn from each other. They focus less on what is difficult, and more on what is possible. Then they write specific "action plans" to practice the new self-management skills they learned, and thus they make those skills into new habits.

Each discussion group had 2 lay leaders. Most of the leaders either had a chronic disease or had personal experience with a chronic disease in one of their family members. Their function was not to teach, but to facilitate and manage the discussions, and for that purpose they first underwent structured training. During their training, the trainees "...experience every activity in the workshop's six sessions, set and report success on their own action plans, practice-teach two activities with a co-leader, and practice handling difficult people in groups" (page 9 of reference [@pone.0065316-Implementation1]). As this self-management program is implemented in Japan, the leader trainees undergo approximately 35 hours of training. For example, a recent training course was held from 9∶00 AM to 4∶30 PM over 5 days. [@pone.0065316-Japan2]People with different diagnoses attended the same sessions together. There was 1 session each week for 6 consecutive weeks. Between August, 2006 and July, 2011, 87 programs of 6 sessions each were held throughout Japan.

Measurements {#s2c}
------------

Socio-demographic and other information were obtained via self-administered questionnaires. Those questionnaires also contained the Hospital Anxiety and Depression scale (HADS) [@pone.0065316-Matsudaira1], [@pone.0065316-McDowell1]. That scale comprises questions about the frequencies of symptoms of anxiety and of depression in the past week. Separate scores were computed for anxiety (7 questions) and depression (7 questions). Possible scores on each question are 0, 1, 2, and 3, and thus the possible total scores on each scale range from 0 to 21. Higher scores indicate more symptoms and more frequent symptoms, i.e., more distress. In the present study, Cronbach's coefficient alpha was 0.84 for the anxiety scale and 0.75 for the depression scale. Those values are typical for these scales [@pone.0065316-Lorig4], and they are nearly the same as those reported from a previous study in Japan [@pone.0065316-Matsudaira1].

Study Design and Timing of Measures {#s2d}
-----------------------------------

This was a longitudinal cohort study in which data were collected four times over one year. Baseline data were collected before the first group-discussion session, and follow-up questionnaires were sent by postal mail 3 months, 6 months, and 12 months later ([Figure 1](#pone-0065316-g001){ref-type="fig"}). A self-addressed post-paid envelope was included. If a follow-up questionnaire was not returned within two weeks, a reminder postcard was sent.

![Timing of data collection.\
Data were collected once before the educational program began (baseline), and then three more times over the following year.](pone.0065316.g001){#pone-0065316-g001}

Definition and Interpretation of Decay of Impact {#s2e}
------------------------------------------------

We used two different definitions of decay of impact, a distribution-based definition and an anchor-based definition. These two are described separately below.

### 1. Distribution-based definition {#s2e1}

To operationalize the concept of decay of impact, we used an index of change similar to Cohen's d [@pone.0065316-Cohen1], which is a standardized effect size. This method of quantifying change was previously used in a very similar context. Specifically, Nolte, et al. [@pone.0065316-Nolte1] studied adults who had chronic medical conditions and participated in self-management educational programs. They measured emotional well-being from the responses to questions regarding "overall health-related negative affect; attitude to life; anxiety, stress, anger and depression." That study is similar to the present study in terms of the population, the intervention, one of the outcome measures, and the focus on changes in individuals. They quantified each individual's change by using a within-person individual effect size: "The within-person individual ES {effect size} was defined as the individual change score divided by the standard deviation of the baseline score of the sample" [@pone.0065316-Nolte1], [@pone.0065316-Wyrwich1]. Each of those changes was considered to be "substantial" if it was one half standard deviation or greater. The criterion of one half standard deviation was chosen because previous work regarding effect sizes shows that it "approximates a minimal important difference" [@pone.0065316-Nolte1]. As a criterion for the minimal important difference in many patient groups and for many outcomes, the half standard deviation criterion has a "remarkable universality" [@pone.0065316-Norman1], [@pone.0065316-Norman2].

For each participant, Nolte, et al. analyzed one baseline value and one follow-up value, whereas in the present study we analyzed one baseline value and three follow-up values. For each participant, they identified substantial change by applying the half standard deviation criterion once, whereas we applied it twice (as described below). We considered a participant to have decay of impact if that participant's data met both of the following two conditions: (1) there was substantial improvement after the baseline value was measured, and (2) there was substantial decline after that substantial improvement.

First, using the effect size and the half standard deviation criterion for substantial change, we identified the participants who had substantial improvement, whether it was evident at 3 months or at 6 months (or both). For that step, each participant's change score was the difference between the baseline score and the best of the two intermediate follow-up scores (either the score at 3 months or the score at 6 months, whichever was lower, i.e. whichever indicated less distress).

Next, including only the participants who had substantial improvement, we applied the same "half a standard deviation" criterion again. Specifically, for each participant who had substantial improvement we computed the difference between the best score and the 12-month score, and then we divided the resulting individual change score by the standard deviation of the scores at the time of the best score. Among the participants who had substantial improvement (whether at 3 months or 6 months), those whose 12-month score was at least half a standard deviation higher (i.e., worse) than their best score were said to have decay of impact, because they had substantial decline after their substantial improvement.

### 2. Anchor-based definition {#s2e2}

The half standard deviation criterion is a distribution-based criterion for defining a minimal important difference. In addition to the results obtained using that method, we also report the results obtained using an "anchor-based" method [@pone.0065316-Jaeschke1]. Anchor-based methods depend on an "association between the targeted concept of a PRO {patient-reported outcome} instrument and the same or closely related concept measured by an independent anchor or anchors." [@pone.0065316-Wyrwich2] They have advantages and disadvantages. The advantage of anchor-based methods is that they are strict. According to Cappelleri and Bushmakin [@pone.0065316-Cappellery1], "The chosen anchor should be clearly understood in context and be easier to interpret than the PRO measure of interest, and the anchor should be appreciably correlated with the targeted PRO." Therefore, for the present study an anchor would be appropriate only if it were easier to interpret than the HADS and appreciably correlated with the HADS. It would also need to have "intuitive meaning" [@pone.0065316-Jaeschke1], and it would have to be measured independently of the HADS. The disadvantage of anchor-based methods is that, because they must meet such strict requirements, good anchors are rare. No such anchor was available within the present study. A search of the literature revealed one report of an anchor-based criterion for HADS scores: Puhan, et al. [@pone.0065316-Puhan1]. All of the participants in that study were patients with chronic obstructive pulmonary disease who were in a rehabilitation program. In that study the anchor was the Chronic Respiratory Questionnaire [@pone.0065316-Guyatt1], and the criterion for a minimal important difference was 1.5 points on the each of the HADS subscales ([Table 2](#pone-0065316-t002){ref-type="table"} of reference [@pone.0065316-Puhan1] and the Conclusion of reference [@pone.0065316-Puhan1]). However, the population and the intervention were different from those in the present study. Furthermore, in that study the criterion for HADS scores was tied to results on the Chronic Respiratory Questionnaire ([Table 2](#pone-0065316-t002){ref-type="table"} of reference [@pone.0065316-Puhan1]), but in the present study most of the participants did not have chronic respiratory disease ([Table 1](#pone-0065316-t001){ref-type="table"}).

10.1371/journal.pone.0065316.t002

###### Questionnaire return and non-return at each follow-up time.
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                                                    Baseline   3-month follow-up   6-month follow-up   12-month follow-up
  ------------------------------------------------ ---------- ------------------- ------------------- --------------------
  Returned[(a)](#nt102){ref-type="table-fn"}          643             492                 470                 458
  Not returned[(b)](#nt103){ref-type="table-fn"}       0          151 (23.5%)         173 (26.9%)         185 (28.8%)

Number of questionnaires returned at the time indicated.

Number (%) of questionnaires not returned at the time indicated.

Because no anchor was available within the present study, and also because of the differences between the present study and the study by Puhan, et al. [@pone.0065316-Puhan1], we consider the distribution-based criterion (i.e., half standard deviation) to be the most appropriate criterion for this study. Nonetheless, below we also report results obtained using Puhan, et al.'s anchor-based value. This is done for the sake of completeness, as 1.5 seems to be the only anchor-based criterion reported for the HADS. It is also done so that those results will be available for future analyses of relations between distribution-based and anchor-based methods in general. By the criterion of Phuan et al., a participant was considered to have decay of impact if both of the following two conditions were met: (1) there was an improvement of at least 1.5 points after the baseline value was measured, and (2) there was a decline of at least 1.5 points after that improvement.

Analyses of Decay of Impact {#s2f}
---------------------------

### Prevalence {#s2f1}

For anxiety and depression separately, we computed the percentage of participants who had decay of impact. Prevalences are expressed as percentages of the group as a whole, and also as percentages of those who initially had substantial improvement.

### Timing {#s2f2}

For each participant who had decay of impact, the time at which the decay began was estimated as the time of that participant's lowest (i.e., "best") score. To be able to distinguish those participants in whom the decay began relatively early from those in whom it began later, we included data only from participants who returned all four questionnaires.

### Magnitude {#s2f3}

For each instance in which the definition of decay of impact was met, we defined the magnitude of the decay as the difference between the best value (at 3 months or at 6 months) and the last measured value (at 12 months). Magnitudes of change are shown in HADS-scale units (minimum 0, maximum 21 for each scale), and also in standard-deviation units. Cumulative frequency distributions [@pone.0065316-Wyrwich2] of results from all participants who had substantial improvement at 3 or 6 months are also shown.

The magnitude of anxiety and of depression can also be analyzed in terms of clinical categories. Here we used the cutoffs that were previously used in Japan to define non-cases (scores less than 9), possible cases (scores of 9, 10, and 11), and probable cases (scores greater than 11) [@pone.0065316-Matsudaira1]. Separately, we also used "8 or above" as a definition "caseness," based on the work of Bjelland et al. [@pone.0065316-Bjelland1]. Using those cutoff scores to define clinical categories, we counted the number of participants with decay of impact who moved from one clinical category to another as their status first improved and then declined over the course of the study.

We also compared the magnitude of the decay of impact to the magnitude of previously-reported differences between known groups: university students and psychiatric outpatients in Japan [@pone.0065316-Matsudaira1]. Their mean scores on the anxiety and depression scales were, respectively, 6.5 and 5.9 for the students, and 8.3 and 8.2 for the outpatients. Thus, the university students differed from the psychiatric outpatients by 1.8 points on the anxiety scale and by 2.3 points on the depression scale, and we compared those differences to the magnitude of the decay of impact.

Software {#s2g}
--------

Statistical analyses were done with Microsoft Excel (version 14.2.3) and IBM SPSS version 20.

Ethical Considerations {#s2h}
----------------------

This study was approved by the Research Ethics Committee of the Graduate School of Medicine at the University of Tokyo (IRB document number 1472). Participation in the program and in this research were voluntary. Informed consent was obtained in writing from all participants before the study began.

Results {#s3}
=======

Participants {#s3a}
------------

Among the 643 people who took part in the self-management program, 369 returned all four of the questionnaires. Data from those 369 people were used in this study. The numbers of questionnaires returned and not returned at each follow-up time are given in [Table 2](#pone-0065316-t002){ref-type="table"}. Patterns of questionnaire return are shown in [Table 3](#pone-0065316-t003){ref-type="table"}. There was no significant difference between the participants who returned all of the questionnaires and those who did not return one or more of the questionnaires, with regard to the number of diagnoses, or with regard to the depression score at baseline ([Table 4](#pone-0065316-t004){ref-type="table"}). The mean anxiety score at baseline was 1.05 points higher among those who did not return one or more of the questionnaires ([Table 4](#pone-0065316-t004){ref-type="table"}). The effect size (Cohen's d) for that 1.05-point difference was 0.24, which would generally be considered to be small [@pone.0065316-Cohen1].

10.1371/journal.pone.0065316.t003

###### Eight patterns of questionnaire return.
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  Baseline    3-month follow-up   6-month follow-up   12-month follow-up             Number of participants             Percent of total
  ---------- ------------------- ------------------- -------------------- -------------------------------------------- ------------------
  Yes                Yes                 Yes                 Yes           **369** [(a)](#nt105){ref-type="table-fn"}        57.4%
  Yes                Yes                 Yes                  No                               52                             8.1%
  Yes                Yes                 No                  Yes                               31                             4.8%
  Yes                No                  Yes                 Yes                               35                             5.4%
  Yes                Yes                 No                   No                               40                             6.2%
  Yes                No                  Yes                  No                               14                             2.2%
  Yes                No                  No                  Yes                               23                             3.6%
  Yes                No                  No                   No                               79                            12.3%

Yes: questionnaire returned; No: questionnaire not returned.

Data from these 369 participants were used in this study. Only data from participants who returned all four questionnaires were used, because those were the only participants regarding whom it was possible to determine, for each individual who had decay of impact, whether that decay began at 3 months or at 6 months after the baseline measurement.

10.1371/journal.pone.0065316.t004

###### Comparison of those who returned all 4 questionnaires and those who returned fewer than 4.

![](pone.0065316.t004){#pone-0065316-t004-4}

                                  All who were eligible for the study[(a)](#nt110){ref-type="table-fn"}   Those who returned all 4 questionnaires   Those who returned fewer than 4 questionnaires
  ------------------------------ ----------------------------------------------------------------------- ----------------------------------------- ------------------------------------------------
  Number of diagnoses                          1 (1, 12)[(b)](#nt111){ref-type="table-fn"}                               1 (1, 7)                                     1 (1, 12)
  Anxiety score at baseline                                     6.99±4.42                                                6.54±4.08                                    7.59±4.78
  Depression score at baseline                                  7.35±3.96                                                7.23±3.90                                    7.53±4.01

Tests for differences between those who returned all 4 questionnaires and those who returned fewer than 4:

For the number of diagnoses, *U* = 50464.5, *p* = 0.646, *r* = 0.02.

For anxiety scores at baseline, *t*(530) = 2.93, *p* = 0.003, *d* = 0.24 (*df* adjusted due to unequal variances).

For depression scores at baseline, *t*(640) = 0.94, *p* = 0.344, *d* = 0.07.

The people who were eligible for the study were adults who had at least one chronic medical condition and took part in an educational program to enhance their ability and confidence to self-manage their chronic condition(s).

Median (minimum, maximum). The minimum is the same as the median because many people (336, 52.3%) had only one diagnosis. For the distribution of number of diagnoses among all who were eligible for the study, skewness was 2.49.

Approximately four fifths (80.2%) of the participants were women, and they ranged in age from 19 to 83 years (mean age: 49). Approximately half of them had schooling at or above the college level (49.3%), and slightly more than half were living together with a wife or husband (54.2%). Almost half of them reported having more than one diagnosis (46.6%). Socio-demographic and clinical details are given in [Table 1](#pone-0065316-t001){ref-type="table"}.

Anxiety and Depression at Baseline {#s3b}
----------------------------------

On both anxiety and depression, the scores at baseline covered almost the entire available range ([Table 5](#pone-0065316-t005){ref-type="table"}). On anxiety, 30.4% of the 369 participants had scores of 9 or higher at baseline, which means that they would be classified as either possible cases or probable cases. On depression that percentage was slightly higher: 38.2%.

10.1371/journal.pone.0065316.t005

###### Anxiety and depression scores at baseline, and numbers of participants in the three clinical categories (n = 369).

![](pone.0065316.t005){#pone-0065316-t005-5}

                                                            Anxiety         Depression
  ----------------------------------------------------- ---------------- -----------------
  Mean ± SD                                                6.55±4.08         7.23±3.92
  Median (25%, 75%)                                      6.0 (3.0, 9.0)   7.0 (4.0, 10.0)
  Minimum-maximum[(a)](#nt112){ref-type="table-fn"}          0--18             0--19
  Clinical category[(b)](#nt113){ref-type="table-fn"}                    
  Probable case (score \>11)                               49 (13.3%)       56 (15.2%)
  Possible case (score = 9, 10, or 11)                     63 (17.1%)       85 (23.0%)
  Non-case (score \<9)                                    257 (69.6%)       228 (61.8%)

The lowest possible score is 0 and the highest possible score is 21. Lower scores indicate fewer symptoms and less frequent symptoms.

These are the categories used by Matsudaira, et al. [@pone.0065316-Matsudaira1].

Short-term Changes in Anxiety and Depression {#s3c}
--------------------------------------------

By the time of the first follow-up measurement, which was 3 months after the baseline measurement, anxiety had substantially worsened in 16.3% (60/369) of the participants and it had substantially improved in 27.4% (101/369). In the remaining 56.4% (208/369) there was no substantial change. For depression those percentages were 24.4%, 36.8%, and 38.8%, respectively (90, 136, and 143 of 369).

Prevalence of Decay {#s3d}
-------------------

### Anxiety {#s3d1}

Almost 40% of the participants had substantial improvement in anxiety at 3 months, 6 months, or both (146/369). Decay of impact occurred in 19% of the whole group (70/369). Those 70 participants were 48% of the 146 who had previously had substantial improvement.

### Depression {#s3d2}

Half of the participants had substantial improvement in depression at 3 months, 6 months, or both (189/369). Decay of impact occurred in 24% of the whole group (90/369). Those 90 participants were 48% of the 189 who had previously had substantial improvement.

With Puhan, et al.'s [@pone.0065316-Puhan1] criterion of 1.5 points (rather than the half standard deviation criterion), the prevalence of decay of impact on anxiety was slightly higher (24%, 87/369), and on depression it was essentially the same as with the half standard deviation criterion (25%, 91/369).

Some of the participants had decay of impact on anxiety only and some had it on depression only, but 31 of them had it on both of the measures: i.e., 44% of those with decay on anxiety and 34% of those with decay on depression had decay on both measures.

Timing of Decay {#s3e}
---------------

Regarding timing, the best score was the 3-month value in about one third of the participants who had decay of impact (anxiety: 30%, 21/70; depression 38%, 34/90).

Magnitude of Decay {#s3f}
------------------

The decay-of-impact pattern is easy to see in the results of the within-person analyses ([Figures 2A and 2B](#pone-0065316-g002){ref-type="fig"}) but not in the whole-group summaries ([Figures 2E and 2F](#pone-0065316-g002){ref-type="fig"}). By definition, the smallest possible decay of impact was half a standard deviation, so the frequency distributions of those magnitudes were truncated at 0.5 and were right-skewed ([Table 6](#pone-0065316-t006){ref-type="table"}). The median magnitudes of the decay on anxiety and on depression were similar: 4 points, which was about 1 standard deviation ([Table 6](#pone-0065316-t006){ref-type="table"}).

![Box-and-whisker plots showing scores on the anxiety and depression scales at the four measurement times.\
The line inside each box indicates the median, the bottom and top indicate the 25th and 75th percentiles, and the ends of the whiskers indicate the 10th and 90th percentiles. Lines connecting the medians were drawn to show patterns of change over time. Higher scores indicate more symptoms and more frequent symptoms. The horizontal dotted lines show the criteria used to define non-cases (scores ≤8), possible cases (scores of 9, 10, and 11), and probable cases (scores ≥12) [@pone.0065316-Matsudaira1]. Panels (A) and (B) show the results from the participants who had substantial improvement that was followed by substantial decline. The decay-of-impact pattern is clearly visible: First the scores decreased (improvement) and later they increased (worsening). It is also clear that, as part of the decay of impact, many participants moved among the clinical categories. Specifically, many of them moved into a better clinical category within the first half of the follow-up year and by the time of the last measurement they had returned to a worse category. For (A), n = 70, and for (B), n = 90. Panels (C) and (D) show the results from the participants who had substantial improvement that was *not* followed by substantial decline. These participants did not have decay of impact. For (C), n = 76, and for (D), n = 99. Panel (E) shows the data from (A) and (C) combined (n = 146), and panel (F) shows the data from (B) and (D) combined (n = 189). When the data are combined the decay of impact is almost completely obscured.](pone.0065316.g002){#pone-0065316-g002}

10.1371/journal.pone.0065316.t006

###### Magnitude of decay of impact.

![](pone.0065316.t006){#pone-0065316-t006-6}

                                           Anxiety (n = 70)   Depression (n = 90)
  -------------------------- ------------ ------------------ ---------------------
  HADS score units                                           
                              Mean ± SD       5.64±3.43            4.65±2.58
                                Median           4.0                  4.0
                              (25%, 75%)      (3.0, 8.0)          (3.0, 6.0)
                               Skewness          0.94                1.13
  Standard-deviation units                                   
                              Mean ± SD       1.47±0.90            1.19±0.66
                                Median           1.1                  1.0
                              (25%, 75%)      (0.8, 1.9)          (0.7, 1.6)
                               Skewness          1.01                1.12

The cumulative frequency distributions show results obtained from all of the participants who had substantial improvement at 3 months or 6 months, whether or not they later had decay of impact ([Figure 3](#pone-0065316-g003){ref-type="fig"}). These curves show the distribution of changes measured from the time of the best score to the end of the follow-up year, to illustrate the full range of changes measured over that time.

![Cumulative frequency distributions and histograms of changes from the time of the best score to the end of the follow-up year.\
The cumulative frequency distributions in panel (A) show changes in scores on the anxiety and depression scales. On these scales, higher scores indicate more distress. Thus, change scores less than zero indicate improvement and change scores greater than zero indicate decline. Changes are shown in standard-deviation units. Vertical lines indicate half a standard deviation above and below zero. By the definition used in this study, increases of half a standard deviation or more were considered to indicate substantial worsening of anxiety or depression. These results are from participants who had substantial improvement between baseline and 3 months, between baseline and 6 months, or both: n = 146 for anxiety, and n = 189 for depression. The changes shown occurred between the time of the best score (i.e., at 3 or at 6 months) and the end of the follow-up year. Thus, points to the right of the vertical line at +0.5 indicate substantial decline in participants who had previously had substantial improvement, i.e. decay of impact. Displays such as (A) illustrate the full range of the measured changes, and allow one to easily see the proportion of participants in whom the magnitude of change meets or exceeds any given value. The histograms in panels (B) and (C) were constructed from the same data used to construct the cumulative frequency distributions in panel (A). Both histograms show distributions that are slightly positively skewed.](pone.0065316.g003){#pone-0065316-g003}

During the follow-up year, many participants with decay of impact moved among the three clinical categories of non-case, possible case, and probable case. For both anxiety for depression, about half of them moved into a less severe category early in the follow-up year, and about half of them moved into a more severe category by the time of the 12-month measurement. Specifically, between the time of the best score and the time of the 12-month score, 50% (35/70) of those with decay of impact moved into a more severe anxiety category and 48% (43/90) of them moved into a more severe depression category. As judged by the criterion of a score of 8 or higher for clinical "caseness" [@pone.0065316-Bjelland1], in more than half of the participants who had decay of impact that decay involved a change in status from non-case to case: 67% (47/70) for anxiety, and 62% (56/90) for depression.

Regarding known groups, in Japan, university students differed from psychiatric outpatients by 1.8 points on the anxiety scale and by 2.3 points on the depression scale [@pone.0065316-Matsudaira1], which were approximately half as large as the decay of impact in the present study: The median magnitude of the decay was 4 points, both on anxiety and on depression ([Table 6](#pone-0065316-t006){ref-type="table"}).

Discussion {#s4}
==========

Decay of Impact: Main Findings {#s4a}
------------------------------

The within-person analyses revealed patterns that were almost completely obscured by whole-group summaries (compare [Figure 2A](#pone-0065316-g002){ref-type="fig"} with 2E, and [Figure 2B](#pone-0065316-g002){ref-type="fig"} with 2F). This is consistent with the hypothesis that decay of impact occurs only in a subgroup of these programs' participants [@pone.0065316-Park1].

The main findings regarding prevalence, timing, and magnitude of the decay of impact are as follows. First, about 40%--50% of all of the participants had substantial improvement within the first six months, and, both on anxiety and on depression, about half of those who had substantial improvement later had substantial decline. This is also consistent with the hypothesis that decay of impact occurs only in a subgroup. Second, in about one third of the participants the decay began 3 months after the baseline measurements. Third, on both anxiety and depression the median magnitude of the decay of impact was 4 points, which was about 1 standard deviation. Many participants first moved into less severe clinical categories, but later "decayed" back into a more severe clinical category.

Timing of Decay of Impact {#s4b}
-------------------------

Because no previous studies have focused on the decay of impact after this type of educational program, it is not possible to compare the timing of decay found here with previous findings. However, some studies have been done in related areas. Krebs et al. [@pone.0065316-Krebs1] meta-analyzed a total of 88 studies of computer-tailored interventions intended to influence various health-related behaviors (smoking cessation, dietary fat reduction, increasing fruit and vegetable intake, physical activity, and mammography screening). They found large variation between studies, but overall there was a decay of impact that began 4 to 6 months after the baseline measurements (see [Figure 1](#pone-0065316-g001){ref-type="fig"} in reference [@pone.0065316-Krebs1]), which is generally consistent with the present results. Hennessy et al. [@pone.0065316-Hennessy1] studied the timing of the decay of impact after an intervention to increase self-efficacy for condom use to prevent HIV infection. Their goal was to determine when reinforcement should be given, and they found that the decay of impact began less than 3 months after the end of the initial intervention. That finding is also consistent with the implication of the present findings, which is that reinforcements should start early.

Interpreting the Magnitude of the Decay of Impact {#s4c}
-------------------------------------------------

One basic question about the decay of impact is whether it is large enough to merit further attention. When using Cohen's d [@pone.0065316-Cohen1] or a similar effect size, it is common to interpret effects of half a standard deviation or larger as important [@pone.0065316-Norman1], [@pone.0065316-Norman2], [@pone.0065316-Wyrwich2], and by that criterion every instance of decay reported here was important, but of course that follows (tautologically) from the operational definition of decay of impact that we used.

Another approach to interpretation involves cutoff points that define clinical categories. This approach is not ideal, because there may be disagreement about the most appropriate number of categories and about clinical "gold standards" for anxiety and for depression. Another disadvantage is that categorization always causes loss of information [@pone.0065316-Bennette1]. Nonetheless, we discuss categories of HADS scores here because they are used so commonly.

When clinical categories are used, it would be reasonable to regard an instance of decay of impact as clinically important if it entailed a change in status from a less severe to a more severe category. Various cutoff points defining clinical categories have been proposed [@pone.0065316-McDowell1], [@pone.0065316-Barth1]. The cutoffs that were previously used in Japan define three categories: non-cases, possible cases, and probable cases [@pone.0065316-Matsudaira1]. As noted above, by those criteria, the decay was clinically important in about half of the participants, both on anxiety (50%) and on depression (48%).

The results were slightly different when two clinical categories were used rather than three. Bjelland et al. [@pone.0065316-Bjelland1] defined two categories. They reviewed 24 studies in which HADS results were compared with diagnoses "made by a structured or semistructured diagnostic interview." They found that for both anxiety and depression scores "in most studies an optimal balance between sensitivity and specificity was achieved when caseness was defined by a score of 8 or above" [@pone.0065316-Bjelland1]. Thus, if the decay of impact entailed an increase from a score below 8 to a score of 8 or higher, then it would be judged to be a clinically important worsening (that is, a change in status from non-case to case). As noted above, by that criterion, the decay was clinically important in more than half of the participants, both on anxiety (67%) and on depression (62%).

Therefore, whether the number of clinical categories used was two [@pone.0065316-Matsudaira1] or three [@pone.0065316-Bjelland1], it is clear that there was clinically important improvement followed by clinically important worsening in half or more of those who had decay of impact. That finding may underestimate the importance of the decay. Bennette and Vickers [@pone.0065316-Bennette1] illustrate how information can be lost when data are categorized by quantiles, and the same point can also apply to categorization by other criteria. For example, if a person's HADS depression score increases from 12 to 20 that person would not move from a less severe to a more severe category, although the clinical worsening might be very important. It is important to remember that the utility of clinical categories is limited. In the present context, important declines could be overlooked if the decay of impact is viewed only as movement between categories.

Yet another approach to judging the importance of the decay of impact is to compare its magnitude with the magnitude of the difference between known groups. We were able to make such a comparison using results from a study of university students and psychiatric outpatients in Japan [@pone.0065316-Matsudaira1]. In that study, those two groups differed by 1.8 points on the anxiety scale and by 2.3 points on the depression scale. In the present sample of adults in Japan who had chronic medical conditions, the median magnitude of the decay of impact was 4 points on both scales ([Table 6](#pone-0065316-t006){ref-type="table"}). Therefore, the decay was approximately twice as large as the difference between university students and psychiatric outpatients.

Operational Definitions of Decay of Impact {#s4d}
------------------------------------------

To define the decay of impact, in this study we used a distribution-based method incorporating the "half a standard deviation" criterion. No appropriate anchor-based criterion was available from within the study. Also, the half standard deviation criterion is known to be widely applicable [@pone.0065316-Norman1], [@pone.0065316-Norman2], [@pone.0065316-Wyrwich2]. This method was used previously to define "substantial" changes in a similar outcome (emotional well-being) in a similar population that underwent a similar intervention [@pone.0065316-Nolte1].

As an example of a different definition of decay of impact, in one study relapse was defined by using a disease-specific measure that included self-identification as a "relapser" [@pone.0065316-Caplin1]. Another possibility would be to estimate the standard error of measurement, which depends on estimates of score reliability [@pone.0065316-Wyrwich2], [@pone.0065316-Guyatt2], although that criterion is used less commonly than the half standard deviation criterion [@pone.0065316-McLeod1]. Yet another possibility would be to do a separate study to find, for minimal important changes in HADS scores, an anchor-based criterion that is appropriate to populations such as this one: adults who participate in education for self-management of chronic illness and who have a wide variety of diagnoses and multimorbidities. Such a study would require an index of anxiety that has intuitive meaning, is relatively strongly correlated with HADS anxiety scores, is measured independently of the HADS, and is easier to interpret than the HADS. It would also require a similar index of depression.

Further analysis of the decay of impact might benefit from techniques developed specifically for analyzing longitudinal data [@pone.0065316-Kenny1], or from structural equation modeling and multilevel modeling of individual growth curves [@pone.0065316-Hennessy1], [@pone.0065316-McArdle1].

Limitations, and Implications for Further Study {#s4e}
-----------------------------------------------

One limitation of this study is that we had no information about why some participants did not return one or more of the follow-up questionnaires (i.e., drop outs). With regard to the number of diagnoses and also with regard to depression scores at baseline, those participants did not differ from the participants who returned all of the follow-up questionnaires ([Table 4](#pone-0065316-t004){ref-type="table"}). Their anxiety scores at baseline were higher, but by only 1.05 points, which was 0.24 standard deviations ([Table 4](#pone-0065316-t004){ref-type="table"}). That difference is small by Cohen's criteria [@pone.0065316-Cohen1]. It is also smaller than both the distribution-based [@pone.0065316-Norman1], [@pone.0065316-Norman2] and the anchor-based [@pone.0065316-Puhan1] criteria for a minimal important difference. The drop outs from the present study remain largely unexplained. Nonetheless, it might be possible to increase participation in studies that use postal questionnaires, as the present study did. Techniques for increasing responses to postal questionnaires have been studied, some of them have been found to be effective, and those should be used to maximize participation in long-term follow-up studies [@pone.0065316-Edwards1].

The precision of the estimate of the time of the start of decay is limited by the fact that data were collected only twice during the year that elapsed between the first and last measurements. More frequent measurements would certainly be useful. If the burden on participants is small, then even daily measurements might be possible [@pone.0065316-Gwaltney1]. The present results suggest that about one third of the participants who have decay of impact and therefore need reinforcement are likely to need it no later than 6 weeks after the end of the workshops.

Another limitation is that we have little information about possible side effects during the program. By the time of the first follow-up measurement, anxiety had substantially worsened in 16% of the participants and depression had substantially worsened in 24% (as noted in the Results section above). Some worsening in mental health might be expected in the natural course of a chronic medical condition. However, in the present study that worsening might also have been due to symptom sensitization or other unwanted events that can be caused by psychotherapeutic and health-education interventions [@pone.0065316-Linden1], [@pone.0065316-Muschalla1]. Of course such events should be recognized and, as much as possible, prevented. This issue is not directly related to the questions of the prevalence, timing, and magnitude of the decay of impact, but it does have important implications. For example, the frequency of side effects could be one index by which programs are evaluated. The possibility of side effects also underscores the importance of studying changes in individuals rather than only in groups. For example, if it were possible to know that a particular patient is at a high risk of experiencing a side effect of an educational program, then the clinician might choose not to refer that patient to the program. In future studies, Linden's schema for defining and classifying adverse treatment effects [@pone.0065316-Linden1] could be adapted from its original context of psychotherapy to self-management education for people with chronic medical conditions.

For further understanding of the decay of impact, it will be important to analyze not only data from longitudinal cohort studies such as this one, but also data from randomized trials with a control group. Randomized trials would be useful because they might reveal patterns of change occurring even in the absence of interventions. For example, while a subgroup of those who receive the intervention have improvement followed by worsening (as documented in the present study), those who do not receive the intervention might experience even greater declines, in which case the intervention could be judged to have been beneficial relative to the control. Randomized trials could also clarify the possible role of regression artifacts [@pone.0065316-Campbell1] (the correlations between the scores used to compute the changes shown in [Figure 3](#pone-0065316-g003){ref-type="fig"} were 0.52 for anxiety and 0.59 for depression).

In part because the decay of impact has not been studied before, there is a need for replication, to determine the extent to which these findings can be generalized to other groups of people with chronic illnesses. Four fifths of the participants were women ([Table 1](#pone-0065316-t001){ref-type="table"}), so these results may not apply to groups with high proportions of men. However, the high proportion of women in this study is probably not an important limitation, because most educational programs of this kind enroll many women and relatively few men [@pone.0065316-Park2]. Specifically, in 17 studies that, like the present study, focused on self-management of chronic illness [@pone.0065316-Fu1]--[@pone.0065316-Jerant2], the percentage of women participants ranged from 61.1% [@pone.0065316-Smith1] to 88.9% [@pone.0065316-Yip1]. The percentage in the present study was within that range: 80.2%.

One possible explanation of any apparent improvement or worsening is response shift [@pone.0065316-Schwartz1]. The concept of response shift has already been applied to outcomes of health-education programs such as this one [@pone.0065316-Osborne1]--[@pone.0065316-Ahmed1]. For response shift to account completely for the apparent decay of impact in the present study it would have to have occurred in opposite directions sequentially. When future longitudinal studies are designed, the possibility of response shift should be taken into account, not least because response shift can be desirable in this context [@pone.0065316-Osborne1].

Conclusions, and Practical Implications Regarding Reinforcements {#s4f}
----------------------------------------------------------------

The magnitude of the decay of impact after education for self-management of chronic conditions can be quantified by using a distribution-based criterion for a minimal important difference in scores on psychometric scales (in this case, the HADS).

To the best of our knowledge, these results show the first measurements of the magnitude and timing of that decay. Following from this first step, future work should focus not only on replication, on comparisons with controls, on response shift, and on possible side effects, but also on identifying predictors of decay.

It is reasonable to assume that the existence of clinically important decay of impact indicates a need for reinforcement (or at least a need for better tests of reinforcements). These findings imply that reinforcement designed to prevent increases in anxiety and depression was needed as early as 3 months after the baseline measurement (which was 6 weeks after the program ended), and that it was needed by about 20% of this program's participants.
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